Concord Medical Services Holdings Limited ADS (Each represents three ordinary shares) (CCM): Price and Financial Metrics
CCM Price/Volume Stats
| Current price | $5.67 | 52-week high | $26.70 |
| Prev. close | $5.07 | 52-week low | $3.82 |
| Day low | $5.00 | Volume | 13,496 |
| Day high | $6.17 | Avg. volume | 18,933 |
| 50-day MA | $7.28 | Dividend yield | N/A |
| 200-day MA | $7.54 | Market Cap | 24.61M |
CCM Stock Price Chart Interactive Chart >
Concord Medical Services Holdings Limited ADS (Each represents three ordinary shares) (CCM) Company Bio
Concord Medical Services Holdings Limited operates a network of radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy, and diagnostic imaging services. The company was founded in 2007 and is based in Beijing, China.
Latest CCM News From Around the Web
Below are the latest news stories about CONCORD MEDICAL SERVICES HOLDINGS LTD that investors may wish to consider to help them evaluate CCM as an investment opportunity.
Concord Medical Schedules 2023 Annual Meeting of ShareholdersConcord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2023 annual general meeting of shareholders (the "Meeting") on December 26, 2023, at 10:00 a.m. (Beijing Time). The meeting will be held |
Concord Medical Reports Financial Results for the First Half of 2023Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers and cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited consolidated financial results for the six months ended June 30, 2023[1]. |
Concord Medical Services Holdings Limited (NYSE:CCM) Could Be Riskier Than It LooksWith a median price-to-sales (or "P/S") ratio of close to 1.3x in the Healthcare industry in the United States, you... |
Concord Medical Services Holdings (NYSE:CCM) shareholders are up 18% this past week, but still in the red over the last five yearsThis week we saw the Concord Medical Services Holdings Limited ( NYSE:CCM ) share price climb by 18%. But don't envy... |
Concord Medical Services Holdings Full Year 2022 Earnings: CN¥5.61 loss per share (vs CN¥18.79 loss in FY 2021)Concord Medical Services Holdings ( NYSE:CCM ) Full Year 2022 Results Key Financial Results Revenue: CN¥472.1m (down... |
CCM Price Returns
| 1-mo | -23.27% |
| 3-mo | 1.02% |
| 6-mo | 41.71% |
| 1-year | -57.69% |
| 3-year | -81.41% |
| 5-year | -77.23% |
| YTD | -48.45% |
| 2023 | -32.93% |
| 2022 | -18.00% |
| 2021 | -27.01% |
| 2020 | 2.71% |
| 2019 | -25.06% |
Continue Researching CCM
Here are a few links from around the web to help you further your research on Concord Medical Services Holdings Ltd's stock as an investment opportunity:Concord Medical Services Holdings Ltd (CCM) Stock Price | Nasdaq
Concord Medical Services Holdings Ltd (CCM) Stock Quote, History and News - Yahoo Finance
Concord Medical Services Holdings Ltd (CCM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...